NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your New Fortress Energy Inc. (NASDAQ:NFE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/new-fortress-energy-inc-lawsuit-submission-form?prid=103935&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of WisdomTree, Inc. ("WisdomTree" or the "Company") (NYSE:WT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether WisdomTree and certain of its officers and/or directors have engaged

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Liquidia Corporation ("Liquidia" or the "Company") (NASDAQ:LQDA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Liquidia and certain of its officers and/or directors have engaged

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Levi & Korsinsky, LLP is investigating potential claims on behalf of individuals who purchased video games on, or otherwise subscribed to the Ubisoft Entertainment SA (Ubisoft) website. Legally protected data may have been intercepted during transactions, particularly for customers who purchased video games featuring cut

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Methode Electronics, Inc. (NYSE:MEI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/methode-electronics-inc-lawsuit-submission-form?prid=103940&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Fulcrum Therapeutics, Inc. ("Fulcrum Therapeutics, Inc.") (NASDAQ:FULC) concerning possible violations of federal securities laws. Fulcrum announced on September 12, 2024, that "its Phase 3 REACH trial evaluating losmapimod in patients with FSHD, did

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rentokil Initial plc ("Rentokil Initial plc") (NYSE:RTO) concerning possible violations of federal securities laws. Rentokil disclosed on September 11, 2024, that it expected full-year adjusted pretax profit of approximately £700 million, compared to

International Game Technology PLC (“IGT”) (NYSE: IGT) announced today that Shondra DeLoach-Perea, IGT Vice President Field Services, Call Centers and Technology Operations, has been named a recipient of Global Gaming Women’s (GGW) 2024 “Patty Becker Pay it Forward Award.”The annual award program honors women in the gaming industry who have contributed to GGW’s initiatives and

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Gogoro Inc. ("Gogoro Inc.") (NASDAQ:GGR) concerning possible violations of federal securities laws. Gogoro announced the resignation of its Chief Executive Officer Horace Luke on September 13, 2024. Mr. Luke’s resignation followed "internal investigations

ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate virtually in a fireside chat at the TD Cowen 4th Annual